Randomized Controlled Trial of the Alma Peer Mentoring Program for Pregnant Women Experiencing Depression

Sponsor
University of Colorado, Boulder (Other)
Overall Status
Completed
CT.gov ID
NCT02883686
Collaborator
Kaiser Permanente (Other), Emory University (Other)
27
2
2
14.7
13.5
0.9

Study Details

Study Description

Brief Summary

Women have double the odds of getting depressed as men and commonly experience depression during the childbearing and early parenting years. Many new and expectant mothers who experience depression never receive help. Alma is a new program, collaboratively developed by a team of researchers, clinicians, and mothers who have personal experience with depression, to support women experiencing depression during pregnancy and the postpartum period. In the Alma program, mothers who themselves have experienced and recovered from depression during the perinatal period, are trained to provide peer mentoring to depressed new and expectant mothers. Peer mentors are trained by professionals who are experts in using skills to recover from depression. These skills are informed by an evidence-based framework called Behavioral Activation (BA). Peer mentors do not provide psychotherapy and are not licensed mental health providers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Alma
N/A

Detailed Description

Women have double the odds of getting depressed as men and commonly experience depression during the childbearing and early parenting years. Many new and expectant mothers who experience depression never receive help.

Alma is a new program, collaboratively developed by a team of researchers, clinicians, and mothers who have personal experience with depression, to support women experiencing depression during pregnancy and the postpartum period. We call this program Alma because the meaning of the word, in English and Spanish, captures what we hope moms will feel when they connect with this program. In English, the meaning comes from the Latin word for "nourishing" and "kind," and in Spanish, the meaning is "soul." Through the unique synergy of science and community, the Alma program provides the tools and support needed to nourish moms in supporting their own well-being.

In the Alma program, mothers who themselves have experienced and recovered from depression during the perinatal period, are trained to provide peer mentoring to depressed new and expectant mothers. Peer mentors are trained to provide 6-10 mentoring meetings with each of the new and expectant mothers with whom they are paired. The peer mentors are trained by professionals who are experts in using skills to recover from depression. These skills are informed by an evidence-based framework called Behavioral Activation (BA). Peer Mentors are trained to support and encourage self-monitoring, scheduling activities, solving problems, and bridging to informal and formal professional support. Peer mentors draw on their training and own lived experience to provide hope and reduce the social isolation and stigma associated with perinatal depression. Among the evidence-based approaches to help people recover from depression, Alma uses BA as a lens because many studies have demonstrated that these skills are effective in recovering from depression. It has been provided in a self-guided format and by lay counselors and licensed mental health providers. Peer mentors do not provide psychotherapy and are not licensed mental health providers.

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants are randomly assigned to the Alma intervention or to Usual CareParticipants are randomly assigned to the Alma intervention or to Usual Care
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effectiveness of the Alma Peer Mentoring Program for Pregnant Women With Depression
Actual Study Start Date :
Feb 6, 2019
Actual Primary Completion Date :
Apr 28, 2020
Actual Study Completion Date :
Apr 28, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Alma Mentoring plus usual care

Alma peer-mentoring

Behavioral: Alma
Alma peer-mentoring

No Intervention: Enhanced Usual Care

Usual care for depression within the Kaiser Permanente of Colorado healthcare system plus study monitoring of depression symptoms and feedback.

Outcome Measures

Primary Outcome Measures

  1. Change in Patient Health Questionnaire (PHQ-9) score [Every 2 weeks for the first 12 weeks of the study, then monthly until 3-months postpartum]

    Self-report measure of depression symptoms.

Secondary Outcome Measures

  1. Change in Generalized Anxiety Disorder Questionnaire (GAD-7) score [Every 2 weeks for the first 12 weeks of the study, then monthly until 3-months postpartum]

    Self-report measure of generalized anxiety symptoms.

  2. Change in Perceived Stress Scale (PSS-10) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report measure of stress.

  3. Change in WHO Disability Assessment Schedule (WHODAS 2.0) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report measure of health, disability, and functioning.

  4. Parenting Stress Index-Short Form (PSI-4/SF) [3-months postpartum]

    Self-reported stress in the parent-child system.

  5. Change in Behavioral Activation for Depression Scale (BADS) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report questionnaire that assesses activation in daily life: Activation, Avoidance/Rumination, Work/School Impairment, and Social Impairment.

  6. Change in Reward-Probability Index (RPI) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report questionnaire that assess proxy dimensions of response-contingent positive reinforcement: reward probability and environmental suppressors inhibiting access to reinforcement.

  7. Change in Environmental Reward Observation Scale (EROS) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report questionnaire that assess the experience of environmental reward over the past several weeks.

  8. Change in Attitudes Toward Motherhood (AToM) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report questionnaire that assess women's attitudes about motherhood, including beliefs related to others' judgments, beliefs about maternal responsibility, and maternal role idealization.

  9. Working Alliance Inventory - Short Form (Intervention group only) [12-weeks post-randomization]

    Self-report questionnaire that assess participant's working alliance with their peer mentor.

  10. Change in Self- Compassion Scale (SCS) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report measure of self-compassion.

  11. Mother Inventory of Reward Experiences (MIRE) [3-months postpartum]

    Self-report questionnaire assessing reward responsivity in parenting.

  12. Change in Social Support Questionnaire - Short Form (SSQ-SF) score [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Self-report questionnaire assessing social support available to a participant and their perception of the quality of that social support.

  13. Client Satisfaction Questionnaire (CSQ-8) [12-weeks post-randomization]

    Self-report measure of general satisfaction with the Alma program. Participants randomized to treatment as usual will receive a CSQ-8 to measure general satisfaction with Kaiser Permanente of Colorado mental health services.

  14. Change in Effort-Expenditure for Rewards Task (EEfRT) performance [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Computerized behavior task administered remotely that assesses effort-based decision-making.

  15. Change in Experience Sampling Survey response [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Momentary mood and activity assessed by self-report triggered by text-message prompt to complete a survey.

  16. Change in Go/No-Go Task (GNAT) performance [Baseline, 12-weeks post-randomization, 3-months postpartum]

    Computerized behavior task administered remotely that assesses implicit associations pairing the self with both stigma and belonging.

  17. Exit Interview [3-months postpartum]

    An Exit Interview will be administered to solicit participant feedback about the Alma program and recommendations for improvement, including questions about overall program and specific Alma components, including telephone- or videoconference- based delivery, length and number of sessions, spacing between sessions, peer characteristics, and ease of access to peers.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Currently enrolled member of Kaiser Permanente of Colorado (KPCO)

  • Current PHQ-9 score greater than or equal to 10

  • Current Columbia-Suicide Severity Rating Scale (C-SSRS) score less than 3

  • Currently pregnant

Exclusion Criteria:
  • Lifetime diagnosis of bipolar disorder or psychotic symptoms

  • Dementia or cognitive impairment disorder recorded in the medical record

  • Current substance abuse behavior

  • At immediate risk of self-harm

  • Unable to speak and read English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaiser Permanente of Colorado Aurora Colorado United States 80014
2 University of Colorado Boulder Boulder Colorado United States 80309

Sponsors and Collaborators

  • University of Colorado, Boulder
  • Kaiser Permanente
  • Emory University

Investigators

  • Principal Investigator: Sona Dimidjian, PhD, University of Colorado, Boulder
  • Principal Investigator: Arne Beck, PhD, Kaiser Permanente

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Sona Dimidjian, Professor, University of Colorado, Boulder
ClinicalTrials.gov Identifier:
NCT02883686
Other Study ID Numbers:
  • CO-16-2391
First Posted:
Aug 30, 2016
Last Update Posted:
May 6, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sona Dimidjian, Professor, University of Colorado, Boulder
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2020